Dabur India Ltd., founded in 1884, is a leading FMCG company specializing in ayurvedic medicines and consumer products, with a significant shift in strategy amid market challenges. During the pandemic, Dabur implemented a turnaround management strategy, launching 40 new products, focusing on rural markets, and investing in healthcare, leading to substantial growth. The company's successful restructuring and international expansion, driven by CEO Sunil Duggal, has positioned it strongly in the global market, enhancing its brand image and revenue.